ICD-10-CM Billable Code

C85.14

Unspecified B-cell lymphoma, lymph nodes of axilla and upper limb

Clinical Classification Guidelines

Medical Intelligence & Overview

Unspecified B-cell lymphoma with involvement of the lymph nodes in the axilla (armpit) and upper limb refers to a type of cancer that originates in B-lymphocytes, which are a kind of white blood cell responsible for fighting infections. When this lymphoma affects the lymph nodes in the shoulder area and upper arms, it can cause swelling and other symptoms. The term 'unspecified' indicates that the precise subtype of the B-cell lymphoma has not been determined. Understanding this diagnosis helps patients comprehend the nature of the disease, although specific treatment options and prognosis vary depending on various factors.

Causes & Symptoms

Clinical Causes: Genetic mutations affecting B-cell development and function Chronic immune system stimulation or autoimmune diseases Certain infections, such as Epstein-Barr virus (EBV) or Helicobacter pylori Environmental exposures to chemicals or toxins Age-related genetic changes, more common in older adults

Key Symptoms: Painless swelling or enlargement of lymph nodes in the axilla and upper limb Unexplained weight loss Fever that persists over time Night sweats Fatigue or weakness Itching over affected areas In some cases, symptoms related to pressure on nearby structures, such as pain or discomfort

Diagnostic & Treatment

Diagnosis Path: Diagnosing unspecified B-cell lymphoma involves multiple steps to confirm the condition and determine its extent. These include: - Medical history review and physical examination focusing on lymph node areas - Imaging studies such as CT scans or PET scans to assess the spread - Biopsy of affected lymph nodes or tissue to identify malignant cells and determine lymphoma type - Laboratory tests, including blood work, to evaluate overall health and organ function - Additional tests may include bone marrow biopsy or molecular studies to refine the diagnosis

Treatment Protocols: Treatment options depend on the stage of the disease, the patient's overall health, and other individual factors. Common treatments include: - Chemotherapy using various drug combinations to destroy malignant B-cells - Radiation therapy targeted at affected lymph nodes - Biological therapy, such as monoclonal antibodies, to help the immune system attack cancer cells - Targeted therapies that specifically interfere with cancer cell growth - Participating in clinical trials exploring new treatment approaches - Supportive care to manage symptoms and maintain quality of life Each treatment plan is personalized, and ongoing monitoring is essential to assess response and adjust therapy as needed.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C85.14 a billable ICD-10 code?
Yes, C85.14 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C85.14?
Clinical documentation must specify the nature of Unspecified B-cell lymphoma, lymph nodes of axilla and upper limb and any associated comorbidities for accurate reporting.

Cite this Clinical Reference